Logo-apb
Adv Pharm Bull. 2025;15(1): 107-122. doi: 10.34172/apb.43295
PMID: 40636301        PMCID: PMC12235369

Original Article

Targeted Delivery of Bortezomib Using Retinoid-Based Nanoparticle: Modulating Liver Fibrosis through the TGF-β1/Smad3 Pathway

Samaneh Siapoush 1,2 ORCID, Mohammad Rahmati 1,3 * ORCID, Morteza Milani 1,4, Behzad Hatami 5, Nosratollah Zarghami 1,3,6, Abbas Ebrahimi-Kalan 7, Mohammad Reza Zali 5, Kaveh Baghaei 2,5 * ORCID

Cited by CrossRef:


1- Mao X, Chen P, Wubur P, Liu Y, Zhao Y, Zhang S, Guan N, Li B. From mechanisms to anti-fibrotic drugs in hepatic stellate cell research: a global bibliometric analysis with patent and clinical perspectives (2000–2025). Front Pharmacol. 2025;16 [Crossref]